About 60 results
Open links in new tab
  1. Is It Time to Rethink STEMI and NSTEMI Classification? - Medscape

    Feb 4, 2025 · The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision …

  2. Antithrombotic Therapy in ACS: From STEMI Presentation to Follow-up ...

    Email This IN THIS PROGRAM: Case Index Go to Test Questions » Presentation of ACS Case Presentation Fibrinolysis vs PCI Adjunctive Therapy Intervention

  3. Does STEMI Need a Rebrand to ‘Occlusion MI’? - Medscape

    Dec 10, 2024 · In the NSTEMI trials, it looks like going sooner, meaning within the first 24 hours, vs later, meaning 3-5 days, was better.

  4. RIVAL: Radial PCI benefits in STEMI - Medscape

    Oct 26, 2012 · Further analysis of the RIVAL trial has shown impressive reductions in key end points, including all-cause mortality, with the radial approach in patients with STEMI vs non-STEMI patients …

  5. New ESC ACS Guideline Combines STEMI and NSTE-ACS - Medscape

    Sep 8, 2023 · The guideline task force says STEMI and non-ST elevation ACS represent a spectrum, and after the initial triage and management decisions, most of the remaining care follows a common …

  6. STEMI vs non-STEMI in GRACE - Medscape

    Sep 20, 2010 · With non-STEMI patients faring as badly as those with more severe ACS events, investigators say that the late mortality in non-STEMI is underrecognized and that more attention …

  7. MI–Atrial Fibrillation Link May Apply Most to NSTEMI ... - Medscape

    Apr 27, 2015 · The investigators write that the culprit artery is totally occluded by a thrombus in STEMI vs being "patent with a nonocclusive thrombus" in NSTEMI.

  8. ACS Guidelines 2025: Key Points - Medscape

    Apr 24, 2025 · Cardiologists and lead authors, Michelle O'Donoghue and Sunil Rao, discuss the key takeaways from the updated acute coronary syndrome guidelines.

  9. LVEF and CAD Severity Predict Mortality Risk After Non-STEMI

    Sep 23, 2025 · Reduced left ventricular ejection fraction and an increased extent of obstructive coronary artery disease signal an elevated risk for mortality in patients with first-time non-STEMI, a study finds.

  10. #165: What's hot at AHA 2012; PFO-closure trials RESPECT and

    What's hot at AHA 2012; PFO-closure trials RESPECT and PC miss primary end point; prasugrel bests clopidogrel in TRILOGY-ACS angiography cohort; RIVAL: Major benefits with radial PCI in STEMI vs ...